Tag: pretomanid
Health Ministry approves introduction of new shorter treatment regimen for drug-resistant...
BPaLM regimen consisting of four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
TB Alliance applauds WHO’s rapid communication on key changes to treatment...
New guidelines have potential to transform the TB treatment landscape with six-month standard
World TB Day: TB Alliance expresses commitment to accessibility of TB...
The DCGI (Drug Controller General of India) approved TB drug, pretomanid, for conditional access under the National Tuberculosis Elimination Program (NTEP), can play a significant role towards elimination of highly drug-resistant TB in India
Mylan secures DCGI approval for its drug-resistant TB drug, Pretomanid
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years. The approval comes as a result of Mylan’s global collaboration with non-profit drug development partner TB Alliance..................